A systematic review of treatment options for dermal photosensitivity in erythropoietic protoporphyria

Cellular and Molecular Biology

Volumn 55, Issue 1, 2009, Pages 84-97

  Minder, E I ^a   Schneider Yin, X ^a   Steurer, J ^b   Bachmann, L M ^b  

^a TRIEMLI HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Beta carotene; Erythropoietic protoporphyria; Evidence based treatment

Indexed keywords

ACETYLCYSTEINE; ASCORBIC ACID; BETA CAROTENE; CANTHAXANTHIN; CYSTEINE; DIHYDROXYACETONE; HENNA; PHENORO; PLACEBO; PROTOPORPHYRIN;

ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; ERYTHROPOIETIC PROTOPORPHYRIA; HUMAN; PHOTODERMATOSIS; QUALITY CONTROL; SKIN PHOTOSENSITIVITY; SYSTEMATIC REVIEW; ULTRAVIOLET B RADIATION;

ASCORBIC ACID; BETA CAROTENE; CLINICAL TRIALS AS TOPIC; CYSTEINE; HUMANS; PROTOPORPHYRIA, ERYTHROPOIETIC; TREATMENT OUTCOME;

LAWSONIA INERMIS;

EID: 67449147376     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.1170/T841     Document Type: Article

References (48)

1. anonymous, The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 1994, 330: 1029-1035. (Pubitemid 24106559)
2. Baart de la Faille H., Suurmond D., Went L. N., van Steveninck J. and Schothorst A. A., β-carotene as a treatment for photohypersensitivity due to erythropoietic protoporphyria. Dermatologica 1972, 14: 389-394.
3. Barth J., Fickweiler E., Harnack K., Hermann K., Hübner U., Schaarschmidt H., and Schiller F, Beta-Carotin in der Behandlung von Protoporphyrien und polymorphen Lichtdermatosen. Dermatol. Monatsschr. 1984, 170: 244-248. (Pubitemid 14110920)
4. Beckert E., and Metz J., Erythropoetische Protoporphyrie. Klinik und Therapie. Fortschr. Med. 1976, 94: 1981-1986,1995.
5. Bijlmer-Iest J. C., Baart de la Faille H., van Asbeck B. S., van Hattum J., van Weelden H., Marx J. J., and Koningsberger J. C., Protoporphyrin photosensitivity cannot be attenuated by oral N-acetylcysteine. Photodermatol. Photoimmunol. Photomed. 1992, 9: 245-249. (Pubitemid 24018007)
6. Boffa M. J., Ead R. D., Reed P., and Weinkove C., A double-blind, placebo-controlled, crossover trial of oral vitamin C in erythropoietic protoporphyria. Photodermatol. Photoimmunol. Photomed. 1996, 12: 27-30. (Pubitemid 26298022)
7. Collins P., and Ferguson J., Narrow-band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses. Br. J. Dermatol. 1995, 132: 956-963.
8. Corbett M. F., Herxheimer A., Magnus I. A., Ramsay C. A., and Kobza-Black A., The long term treatment with beta-carotene in erythropoietic protoporphyria: a controlled trial. Br. J. Dermatol. 1977, 97: 655-662.
9. Cox T. M., Erythropoietic protoporphyria. J. Inherit. Metab. Dis. 1997, 20: 258-269. (Pubitemid 27273489)
10. de Sélys R., Decroix J., Frankart M., Hassoun A., Willcox D., Pirard C., and Bourlond A., Erythropoietic protoporphyria. Ann. Dermatol. Venereol. 1988, 115: 555-560 (Pubitemid 18194064)
11. Eales L., The effects of canthaxanthin on the photocutaneous manifestations of porphyria. S. Afr. Med. J. 1978, 54: 1050-1052. (Pubitemid 9097119)
12. Fontanellas A., Mendez M., Mazurier F., Cario-André M., Navarro S., Ged C., Taine L., Géronimi F., Richard E., Moreau-Gaudry F., DE Salamanca R., and de Verneuil H., Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic stem cells. Gene Ther. 2001, 8: 618-626 (Pubitemid 32422056)
13. Fusaro R. M., and Johnson J. A., Limited usefulness of artificial light sources. Arch. Dermatol. 1975a 111: 394-396.
14. Fusaro R. M., and Johnson J. A., Protection against long ultraviolet and/or visible light with topical dihydroxyacetone. Implication for the mechanism of action of the sunscreen combination, dihydroxyacetone/ naphthoquinone. Dermatologica 1975b, 150: 346-351.
15. Fusaro R. M., and Rice E. G., The Maillard reaction for sunlight protection. Ann. N.Y. Acad. Sci. 2005, 1043: 174-183. (Pubitemid 41123904)
16. Goerz G., and Ippen H., Carotinoid-Behandlung von Lichtdermatosen. Dtsch. Med. Wochenschr. 1977, 102: 1051-1055.
17. Hennekens C., Buring J., Manson J., Stampfer M., Rosner B., Cook N., Belanger C., LaMotte F., Gaziano M., Ridker P., Willett W., and Peto R., Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N. Engl. J. Med. 1996, 334: 1145-1149. (Pubitemid 26137972)
18. Holme S. A., Anstey A. V., Finlay A. Y., Elder G. H., and Badminton M. N., Erythropoietic protoporphyria in the UK: clinical features and effect on quality of life. Br. J. Dermatol. 2006, 155: 574-581. (Pubitemid 44215489)
19. Krook G., and Haeger-Aronsen B., Erythrohepatic protoporphyria and its treatment with beta-carotene. Acta Derm. Venereol. 1974, 54: 39-44.
20. Kunz R., and Oxman A., The unpredictability paradox: review of empirical comparisons of randomised and nonrandomised clinical trials. BMJ 1998, 317: 1185-1190. (Pubitemid 28488507)
21. Lehmann P., Scharffetter K., Kind P., and Goerz G., Erythropoetische Protoporphyrie: Synopsis von 20 Patienten. Hautarzt 1991, 42: 570-574.
22. Lewis M. B., The effect of beta-carotene on serum vitamin A levels in erythropoietic protoporphyria. Aust. J. Derm. 1972, 13: 75-78.
23. Mathews-Roth M., Beta-carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases. Biochimie 1986, 68: 875-884. (Pubitemid 16099444)
24. Mathews-Roth M., Treatment of erythropoietic protoporphyria with N-acetylcysteine (reply). Arch. Dermatol. 1995, 131: 355.
25. Mathews-Roth M. M., Phototesting as an objective measurement of improvement in erythropoietic protoporphyria. Arch. Dermatol. 1979, 115: 1391-1392. (Pubitemid 10181622)
26. Mathews-Roth M. M., Pathak M. A., Fitzpatrick T. B., Harber L. C., and Kass E. H., Beta-carotene as an oral photoprotective agent in erythropoietic protoporphyria. JAMA 1974, 228: 1004-1008.
27. Mathews-Roth M. M., Pathak M. A., Fitzpatrick T. B., Harber L. H., and Kass E. H., Beta carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases. Arch. Dermatol. 1977, 113: 1229-1232. (Pubitemid 8178523)
28. Mathews-Roth M. M., and Rosner B., Long-term treatment of erythropoietic protoporphyria with cysteine. Photodermatol. Photoimmunol. Photomed. 2002, 18: 307-309. (Pubitemid 35469776)
29. Mathews-Roth M. M., Rosner B., Benfell K., and Roberts J. E., A double-blind study of cysteine photoprotection in erythropoietic protoporphyria. Photodermatol. Photoimmunol. Photomed. 1994, 10: 244-248.
30. Minder E. I., and Schneider-Yin X., Human Hereditary Porphyrias. In "The Textbook of Hepatology: From Basic Science to Clinical to Clinical Practise" (J. Rodes, J.-P. Benhamou, J. Reichen, and M. Rizetto, Eds.), Blackwell Publishing Limited, Malden. 2007
31. Murphy G. M., Diagnosis and management of the erythropoietic porphyrias. Dermatologic. Ther. 2003, 16: 57-64. (Pubitemid 36665997)
32. Niebauer G., Mischer P., and Formanek I., Light-sensitive dermatoses in children. Mod. Probl. Paediatr. 1976, 20: 86-101.
33. Norris P. G., Baker C. S., Roberts J. E., and Hawk J. L., Treatment of erythropoietic protoporphyria with Nacetylcysteine. Arch. Dermatol. 1995, 131: 354-355.
34. Omenn G. S., Goodman G. E., Thournquist M. D., Balmes J., Cullen M. R., Glass A., Keogh J. P., Meyskens F. L., Valanis B., Williams J. H., Barnhart S., and Hammar S., Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 1996, 334: 1150-1155. (Pubitemid 26137973)
35. Pawliuk R., Tighe R., Wise R., Mathews-Roth M., and Leboulch P., Prevention of murine erythropopietic protoporphyria-associated skin photosensitivity and liver disease by dermal and hepatic ferrochelatase. J. Invest. Dermatol. 2005, 124: 256-262.
36. Poh-Fitzpatrick M. B., Wang X., Anderson K. E., Bloomer J. R., Bolwell B., and Lichtin A. E., Erythropoietic protoporphyria: altered phenotype after bone marrow transplantation for myelogenous leukemia in a patient heteroallelic for ferrochelatase mutations. J. Am. Acad. Dermatol. 2002, 46: 861-866.
37. Rice E. G., Dihydroxyacetone naphthoquinone protection against photosensitivity. Dermatologica 1976, 153: 38-43.
38. Richard E., Mendez M., Mazurier F., Morel C., Costet P., Xia P., Fontanellas A., Geronimi F., Cario-André M., Taine L., Ged C., Malik P., de Verneuil H., and Moreau-Gaudry F., Gene therapy of a mouse model of protoporphyria with self-inactivating erythroid-specific lentiviral vector without preselection. Mol. Ther. 2001, 4: 331-338
39. Richard E., Robert E., Cairo-André M., Ged C., Géronimi F., Gerson S. L., de Verneuil H., and Moreau-Gaudry F., Hematopoietic stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase- mediated in-vivo drug selection. Gene Ther. 2004, 11: 1638-1647. (Pubitemid 39530100)
40. Rufener E., Erythropoetische Protoporphyrie: Krankheitsbewältigung aus biopsychosozialer Sicht. Hausarz 1989, 40: 271-275. (Pubitemid 19153066)
41. Rufener E., Schattenspringen. In "Philosophische Fakultät I", University of Zurich, Zurich, 1990.
42. Rufener E., Und fände nirgends Schatten. Psychother. Psychosom. Med. Psychol: 1992, 42: 339-348.
43. Sarkany R., Erythropoietic protoporphyria (EPP) at 40. Where are we now? Photodermatol. Photoimmunol. Photomed. 2002, 18: 147-152.
44. Thomsen K., Schmidt H., and Fischer A., Beta-carotene in erythropoietic protoporphyria: 5 years' experience. Dermatologica 1979, 159: 82-86. (Pubitemid 9220645)
45. Todd D., Clinical implications of the molecular biology of erythropoietic protoporphyria. J Eur Acad. Dermatol. Venereol. 1998, 11: 207-213. (Pubitemid 29010425)
46. von Laar J., Stahl W., Bolsen K., Goerz G., and Sies H., Beta-carotene serum levels in patients with erythropoietic protoporphyria on treatment with the synthetic all-trans isomer or a natural isomeric mixture of beta-carotene. J. Photochem. Photobiol. 1996, 33: 157-162.
47. Wennersten G., Carotenoid treatment for light sensitivity. Acta Dermatol. Venereol. 1980, 60: 251-255.
48. Zaynoun S. T., Hunter J. A. A., Darby F. J., Zarembski P., Johnson B. E., and Frain-Bell W., The treatment of erythropoietic protoporphyria. Experience with betacarotene. Br J Dermatol 1977, 97: 663-668.